Cytoreductive nephrectomy has selective survival benefit in mRCC The Oncology Report SAN FRANCISCO – Only selected patients with synchronous metastases from renal cell carcinoma derive a survival benefit from a cytoreductive nephrectomy, a retrospective cohort study showed. Researchers studied more than 1,600 patients from the ... |
